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SCHEURINK, A. AND S. RITTER. Sympathoadrenal responses to glucoprivation a d lipoprivation i rats. PHYSIOL BEHAV 
53(5) 995-1000, 1993.--The ffects of glucoprivation a d lipoprivation on sympathoadrenal outflow were investigated in rats 
with permanent intra-atrial catheters. Glucoprivation was induced by infusion of a hypoglycemic dose of insulin (3 U/kg) or by 
infusion of the glucose antimetabolite, 2-deoxy-D-glucose (2-DG, 200 mg/kg). Lipoprivation was induced by infusion of sodium 
mercaptoacetate (MA, 600/amol/kg), which blocks beta oxidation of fatty acids. Stress-free blood samples for measurement of 
blood glucose, plasma nonesterified fatty acids (NEFA), and epinephrine (E) and norepinephrine (NE) concentrations were 
collected remotely before and after drug injection. Glucoprivation and lipoprivation differed significantly in their effects on the 
sympathoadrenal system. Both 2-DG- and insulin-induced glucoprivation appeared to increase adrenomedullary secretion selectively, 
leading to dramatically increased plasma E levels. Although plasma NE levels also rose during glucoprivation, other evidence 
suggests hat this effect may be secondary tothe rise in E. In contrast, MA-induced lipoprivation i creased the outflow of NE 
from the sympathetic nerve ndings without asignificant effect on plasma Econcentrations. Plasma E levels rose only late in the 
test, as blood glucose levels began to fall. Results indicate that glucoprivation a d lipoprivation are distinct metabolic signals, 
each capable of seleetively activating one branch of the sympathoadrenomedullary system and thereby facilitating the mobilization 
of metabolic fuels appropriate for the specific metabolic challenge. 
Insulin-induced hypoglycemia 2-DG Mercaptoacetate Glucose Epinephrine Norepinephrine 
INITIATION of food intake and activation of the sympathoad- 
renal system appear to be the primary behavioral nd neuroen- 
docrine responses to a reduction in the availability of energy 
substrates (3,29). These behavioral and sympathoadrenal re-
sponses act in a coordinated fashion to mobilize, redistribute, 
and replenish metabolic fuels. 
With respect to food intake, two specific metabolic controls, 
the glucoprivic and the lipoprivic ontrols, have been identified 
(2, l l, 15,21). These controls timulate f eding in response to de- 
creased glucose utilization (glucoprivation) or decreased fatty 
acid oxidation (lipoprivation) and can be experimentially acti- 
vated by administration of hypoglycemic doses of insulin 
( 1 t,21,25), by glucose antimetabolites such as 2-deoxy-D-glucose 
(2-DG) (l,11,21), or by drugs that block fatty acid oxidation, 
such as sodium mercaptoacetate (MA) (2,12,13,15). 
With respect o the effects of specific metabolic deficits on 
sympathoadrenal activation, only glucoprivation has been stud- 
ied. Both insulin-induced hypoglycemia (3) and 2-DG-induced 
blockade of intracellular glucose metabolism (9) stimulate sym- 
pathoadrenal activity, thereby elevating plasma levels of the cat- 
echolamines pinephrine (E) and norepinephrine (NE). How- 
ever, the effects of lipoprivation on sympathoadrenal activity 
have not yet been examined. Therefore, the primary goal of this 
experiment was to examine and compare the effects of systemic 
2-DG- and insulin-induced glucoprivation with MA-induced li- 
poprivation on sympathoadrenal activity and circulating met- 
abolic fuels. 
Most previous tudies on the effects of glucoprivation on 
sympathoadrenal outflow have been performed in anesthetized 
animals. Anesthesia tself, however, markedly alters ympathetic 
outflow and inhibits adrenal catecholamine release during stress 
(3,26). Therefore, an important aspect of the present study is 
that the sympathoadrenal c techolamine responses toglucopri- 
vation and lipoprivation were measured by remote blood sam- 
pling in conscious, freely behaving rats that were permanently 
cannulated and well habituated tothe experimental procedures 
prior to testing. Such procedures have been shown to be sensitive 
and appropriate for accurate assessment of both basal and stim- 
ulated levels of sympathoadrenal outflow (18,19,23). 
Results of this study indicate that glucoprivation and lipo- 
privation are distinct metabolic signals, each capable of selec- 
tively activating one branch of the sympathoadrenomedullary 
system (the adrenomedullary or sympathetic neuronal branch, 
respectively). These selective responses result in the mobilization 
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of metabolic fuels appropriate for each specific metabolic hal- 
lenge. 
METHOD 
Animals and thmsing 
Male Sprague-Dawley rats obtained from the Washington 
State University Laboratory Animal Resource Center, weighing 
260-320 g at the beginning of the present experiments, were 
used. The animals were individually housed in Plexiglas cages 
at room temperature (20 + 2°C), and had continuous access to 
medium fat, high-carbohydrate food (12,15) and water unless 
otherwise stated. The rats were maintained on a 12-12 h light- 
dark regime (0700-1900 h light), and they were handled and 
weighed every day at 0900 h. 
Heart Cannulation 
Surgery was performed under methoxyflurane (Metafane, 
Pitman Moore) anesthesia. All animals were provided with a 
silicon heart catheter (0.95 mm o.d., 0.50 mm i.d.), inserted into 
the heart hrough the left jugular vein and externalized on the 
top of the skull according to techniques described earlier (24). 
This method allows intravenous infusion and frequent repeated 
blood sampling in unanesthesized, undisturbed, freely moving 
animals (23). The rats were habituated to the blood-sampling 
procedures prior to the start of the experiments. The experiments 
were initiated 1 week after surgery when the rats were above 
their preoperative weights. 
Blood Sampling and Chemical Determinations 
All experiments were performed in the light period between 
0900 and 1200 h after overnight food deprivation. Forty minutes 
before the first blood sample was taken, the animals were con- 
nected to a polyethylene blood-sampling tubing (in mm: 300 
length, 1.25 o.d., 0.75 i.d.). For each experiment, 11 blood sam- 
ples of 0.3 ml each were taken from each rat for determination 
of blood glucose and catecholamine levels (Experiments 1-3) 
and plasma free fatty acids (Experiment 3). After each blood 
sample, a transfusion of the same amount of donor blood was 
given to avoid diminution of the blood volume with related 
changes in bemodynamics. Donor blood was obtained from un- 
disturbed onor rats with permanent heart catheters. Heparin 
was used as the anticoagulant for Experiments 1 and 2. Since 
heparin is known to stimulate lipoprotein lipase and thereby 
release free fatty acids, citrate rather than heparin was used as 
the anticoagulant i  Experiment 3. 
Blood samples were immediately transferred tochilled (0°C) 
centrifuge tubes containing 0.1% EDTA as antioxidant and 10 
#1 heparin solution (500 U/ml) as anticoagulant. Blood glucose 
was measured by the glucose oxidase method (14) with 0.05 ml 
blood taken from the sample. The remaining part was centrifuged 
for 15 rain at 5000 rpm at 4°C, and the supernatant was im- 
mediately stored at -80°C. Plasma catecholamine concentra- 
tions were determined by high pressure liquid chromatography 
(HPLC) in combination with electrochemical detection (ECD). 
The protocol for catecholamine determination was slightly 
modified from published procedures (10). The HPLC-ECD sys- 
tem included an LKB 2150 pump (LKB Instruments, Bromma, 
Sweden), a Rheodyne injection valve with a 100 ul loop, a re- 
versed-phase nucleosil C18 column (length 25 cm, i.d. 4 mm) 
(Gimex, The Netherlands) held at 30°C by a column stove 
(LKB), an ESA 5100 A electrochemical detector with a 5011 
high-sensitive analytical cell and a 5020 guard cell (ESA), and 
a BD 41 two-channel flat recorder (Kipp). Guard cell potential 
in front of the injection valve was +450 mV: the potentials of 
the working electrodes were --50 mV and +350 mY, respectively. 
The mobile phase contained 0.05 M Na-acetate. 0 08':4 heptanc 
sulfonic acid, 0.01% EDTA, 0.01~: NaC1, and 5% methanol 95 ''', 
H:O IpH 4.75). The limit of the detection level for epinephrine 
was 0.010 ng/ml and 0.005 ng/ml for norepinephrinc, lntra- 
and interassay coefficients of variation for thc catccholaminc 
measurements were 2.25':~ and 5.36%, respectiveb. Determi- 
nation of plasma nonesterified fatty acids (NEFA) was pertormcd 
in triplicate 20-ul plasma samples assayed with a WAKO 
NEFA kit. 
P,:t7~erirnent.s 
The aim of the present study was to investigate he efl~cts of 
glucoprivation and lipoprivation on the outflow of catechol- 
amines from the adrenal medulla nd the nerve endings of the 
sympathetic nervous ystem. Therefore, rats were subjected to 
insulin-induced hypoglycemia, intravenous administration f 2- 
deoxy-D-glucose, and blockade of fatty acid oxidation with so- 
dium mercaptoacetate. These experiments were designated Ex- 
periments 1 to 3, respectively. In all experiments, two blood 
samples were taken before administration f the drug to measure 
baseline l vels of the blood components. The experimental drug 
was intravenously injected at t = 0 min. Blood samples were 
taken before and after injection at the time points t = ~ 11, 1, 
2.5, 5, 7.5, 10, 15, 30, 45, 60, and 75 min relative to the ad- 
ministration of the drug. 
In Experiment 1, the effects of intravenous administration 
of a single dose of insulin (NOVO Nordisk Pharmaceuticals Inc, 
3 U/kg) on sympathoadrenal outflow were investigated in six 
rats. Blood glucose concentrations were measured in all blood 
samples, and plasma norepinephrine and epinephrine l vels were 
determined in the samples taken at the time poinls t - t I, 
-1.2.5, 5, 7.5, 10, 45, and 75 min. 
in Experiment 2, the effects of intravenous administration 
of a single dose of 2-DG (Sigma, 200 mg/kg) on sympathoadrenal 
outflow were investigated in six rats. Blood glucose concentra- 
tions were measured in all blood samples, and plasma E and 
NE levels were determined in the samples taken at the time 
points t -11 , -1 ,5 ,  10, 45, and 75 min. 
Finally, in Experiment 3, the effects of intravenous admin- 
istration of a single dose of MA (thioglycolic acid, Sigma, 600 
#mol/kg) on sympathoadrenal outflow were investigated in six 
rats. Blood glucose, plasma NEFA, and plasma E and NE con- 
centrations were measured in all blood samples. 
Data Analysis and Statistics 
Data are expressed as averages _+ SE. Wilcoxon matched- 
pairs signed rank test was used to compare the levels of the 
blood components relative to the baseline level at t = - 1 min. 
Significance was set at p < 0.05. 
RESULTS 
Experiment 1: Insulin-Induced Hypoglycemia 
The results from Experiment 1are presented in Fig. 1. In- 
jection of insulin immediately decreased blood glucose concen- 
trations from baseline levels of 75 _+ 7 mg/dl at t = - 1 min to 
a minimum of 29 + 2 mg/dl at t = 60 rain. The decrease of 
blood glucose was significant at all time points after injection 
of insulin. Plasma E levels increased during insulin-induced hy- 
poglycemia from baseline concentrations of 0.09 _+ 0.03 ng/ml 
at t = - 1 min up to a maximum of 4.73 + 0.98 ng/ml at t = 
60 min. The increase of plasma E was significant at all time 
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FIG. 1. (A) Blood glucose and plasma epinephrine (E) concentrations 
in mg/dl and ng/ml, respectively, before and after a single intravenous 
injection of insulin (3 U/kg). Data are expressed as averages -4- SE. (B) 
Blood glucose and plasma E concentrations in mg/dl and ng/ml, re- 
spectively, before and immediately after a single intravenous injection 
of insulin (3 U/kg). Data are expressed as averages _+ SE. (C) Plasma E 
and norepinephrine (NE) concentrations in ng/ml before and after a 
single intravenous injection of insulin (3 U/kg). Data are expressed as 
averages _+ SE. 
points after t = 5 min. Epinephrine levels started to increase 
when blood glucose levels were between 67 and 52 mg/dl (Fig. 
1C). Plasma NE levels moderately increased from baseline levels 
of 0.14 +_ 0.2 at t = -1  min up to 0.50 _+ 0.07 at t = 45 rain 
during insulin-induced hypoglycemia. The increase of NE was 
significant at all time points after t = 7.5 min. 
Experiment 2." 2-Deoxy-D-Glucose 
The results from Experiment 2 are presented in Fig. 2. Blood 
glucose levels immediately increased after injection of 2-DG from 
baseline levels of 73 _+ 5 mg/dl up to a maximum of 208 + 13 
mg/dl at t = 60 min. Also, plasma E and NE concentrations 
increased after 2-DG injection (from baseline levels of 0.03 _+ 
0.002 and 0.118 + 0.03 ng/ml at t = - 1 rain to maximal evels 
of 3.94 _+ 0.82 and 0.39 + 0.07 at t = 45 min, respectively). The 
increases of blood glucose and plasma E were significant at all 
time points after injection of 2-DG. Plasma NE levels were sig- 
nificantly increased at time point t = 45 min. 
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FIG. 2. (A) Blood glucose and plasma epinephrine (E) concentrations 
in mg/dl and ng/ml, respectively, before and after a single intravenous 
injection of the glucose antimetabolite 2-deoxy-D-glucose (2-DG, 200 
mg/kg). Data are expressed as averages _+ SE. (B) Plasma E and norepi- 
nephrine (NE) concentrations in ng/ml before and after a single intra- 
venous injection of the glucose antimetabolite 2-DG (200 mg/kg). Data 
are expressed as averages +_ SE. 
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Experiment 3." Mercaptoacetate 
The results from Experiment 3 are presented in Fig. 3. In- 
jection of MA caused an increase of blood glucose from baseline 
levels of 85 + 5 mg/dl up to a maximum of 113 + 5 at t = 15 
min after injection. The increase of blood glucose was significant 
at the time points t = 5, 10, 15, and 30 min. Blood glucose then 
declined to levels below baseline (significant at t = 75 min when 
blood glucose levels were 65 + 7 mg/dl). 
Plasma NEFA levels immediately decreased after injection 
of MA from baseline levels of 0.672 _+ 0.033 mEq/l to a mini- 
mum of 0.518 + 0.046 mEq/l at time point t = 7.5 min. There- 
after, plasma NEFA concentrations increased ramatically to 
above baseline with a maximal level of 1.368 _+ 0.147 mEq/l at 
t = 75 min at the termination of the experiment. Plasma levels 
of NEFA were significantly decreased below baseline at time 
point t = 7.5, and were significantly increased after baseline 
levels at all time points after t = 15 min. 
Plasma E concentrations did not not change from baseline 
level (0.05 _+ 0.01 ng/ml) until time point t = 60 min. Then, an 
increase of plasma E levels occurred with a maximum of 0.73 
_+ 0.17 ng/ml at t = 75 rain (significant at the time points t - 
60 and 75 min). At the time points 5 to 15 min after injection 
ofMA, a small but significant enhancement of plasma NE levels 
above baseline levels (from 0.18 _+ 0.2 to 0.22 _+ 0.01 ng/ml) 
occurred. Then, a further increase of plasma NE was seen with 
a maximum of 0.37 +_ 0.05 ng/ml in the last sample of the 
experiment. Plasma NE levels were significantly increased above 
baseline concentrations at all time points between t = 5 and 75 
rain. 
DISCUSSION 
The most striking result of this study was the highly selective 
increase in plasma NE levels in response to MA-induced block- 
ade of fatty acid oxidation. Plasma NE concentrations began to 
rise within minutes after MA injection and remained elevated 
throughout the study. In contrast, plasma E concentrations were 
not significantly elevated above basal evels until 60 min after 
MA injection. The delayed rise in plasma E did not appear to 
be stimulated directly by decreased fatty acid oxidation, but in- 
stead was temporally coupled with declining plasma glucose lev- 
els during the later portion of the test period. Since sympathetic 
nerve endings are the primary source of plasma NE in the rat 
(16,19), these results indicate that lipoprivation isa remarkably 
selective stimulus for activation of sympathetic neurons. 
Plasma catecholamine responses toglucoprivation were sim- 
ilar to those reported previously (9). Both 2-DG and the hypo- 
glycemic dose of insulin increased adrenomedullary secretion, 
as demonstrated bythe marked increase of plasma epinephrine 
(E) concentrations. The relatively high dose of insulin used in 
Experiment 1 caused avery severe hypoglycemia during the last 
phase of the experiment. As a consequence, plasma E reached 
extremely high concentrations, upto 5 ng/ml. Plasma NE was 
also increased uring glucoprivation. Previous results have 
demonstrated that high circulating levels of E increase plasma 
NE concentrations via ~z-adrenoceptor-mediated stimulation of 
neuronal NE outflow (16,19). Therefore, it is likely that the in- 
crease in NE concentration during glucoprivation observed in 
the present study was secondary to the very large increase in 
plasma E. This possibility isconsistent with other evidence dem- 
onstrating that glucoprivation stimulates the adrenomedullary 
branch but not the neuronal branch of the sympathoadrenal 
system (4,6,27,28). Thus, in terms of their direct effects, glu- 
coprivation and lipoprivation may selectively activate different 
components of the sympathoadrenal system. 
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FIG. 3. (A) Blood glucose and plasma epinephrine (E) concentrations 
in mg/dl and ng/ml, respectively, before and after a single intravenous 
injection of the fatty acids antimetabolite mercaptoacetate (MA, 600 
umol/kg). Data are expressed asaverages _+SE. (B) Plasma nonesterified 
fatty acids (NEFA) and norepinephrine (NE) concentrations i  mEq/I 
and ng/ml, respectively, before and after a single intravenous injection 
of the fatty acid antimetabolite MA (600 ~tmol/kg). Data are expressed 
as averages _+SE. 
As reported previously, MA increased plasma NEFA levels 
overall (12,15), after a small decline during'the first 15 min after 
drug injection. The causes of the MA-induced increase in NEFA 
are not known. However, the present results reveal that plasma 
NEFA levels closely parallel the elevation in plasma NE levels. 
Since neuronally released NE appears to mediate white adipose 
tissue lipolysis (17,19), areasonable interpretation f these results 
is that the MA-induced increase in plasma NEFA levels is me- 
diated directly by the increased sympathetic neuronal release of 
NE, coupled with the MA-induced blockade of fatty acid utili- 
zation. 
Administration of MA caused an immediate rise in blood 
glucose concentration. This elevation of glucose appears to be 
a reproducible effect of MA, since it was also observed in an 
earlier study in which MA was administered intraperitoneally 
(12). However, in contrast to results with 2-DG, the elevation 
in glucose by MA was not preceded by a rise in plasma E. There- 
fore, MA-induced elevation of blood glucose concentrations 
CATECHOLAMINE RESPONSES TO LIPOPRIVATION 999 
might be mediated by a different mechanism than 2-DG-induced 
hyperglycemia. This mechanism ay involve activation of sym- 
pathetic neuronal outflow of NE from hepatic nerve endings. 
Several pieces of evidence support this hypothesis. First, plasma 
NE levels were selectively increased by MA, indicating that sym- 
pathetic neurons were generally activated. Secondly, previous 
work has shown that stimulation of the sympathetic nerves to 
the liver may lead to an a-adrenoceptor-mediated increase of 
hepatic glycogenolysis (5,8,20), but that blood-borne NE does 
not stimulate hepatic glycogenolysis ( 17,19). Other mechanisms 
that may participate in the MA-induced increase in blood glu- 
cose, such as increased pancreatic glucagon release, decreased 
insulin production, or changes in adrenoceptor sensitivity to 
peripheral glucose metabolism, have not yet been evaluated. 
After an initial increase in blood glucose levels, which peaked 
15 min after MA injection, blood glucose levels began to decline 
slowly. Beginning 45 min after MA injection, blood glucose was 
reduced significantly relative to the peak values. However, blood 
glucose did not fall significantly below predrug baseline values 
until 75 min after MA injection. It is interesting to note that 
plasma E levels began to rise between 45 and 60 min after MA 
injection, when glucose levels were still above predrug baseline 
and above the expected threshold for stimulation of an adrenal 
medullary response (7). Thus, the time course of the E response 
suggests that sympathoadrenal activation was triggered by the 
relative decline of glucose levels from peak, not from baseline, 
values. This would suggest that a new set-point for glucose ho- 
meostasis was established during lipoprivation, determined in
part by availability of NEFA as an energy substrate. Elevation 
of the glucose set-point by decreased metabolic availability of 
NEFAs might also explain why blood glucose immediately in- 
creased to a higher level after administration f MA. Future 
experiments are in progress to examine the influence of specific 
metabolic fuels on mechanisms governing lucose homeostasis 
and metabolism. 
In conclusion, these experiments demonstrate that glucopri- 
vation and lipoprivation are distinct metabolic signals capable 
of exerting selective control of adrenomedullary nd sympathetic 
neuronal activity, respectively. A primary function of this sym- 
pathoadrenal ctivation is to increase circulating levels of the 
deficient metabolic fuel. The evidence that decreased glucose 
availability exerts a powerful and selective control of adreno- 
medullary secretion is therefore compatible with previous find- 
ings that physiological doses of circulating E, but not NE, can 
stimulate hepatic glucose production i  rats (17,19,22). Similarly, 
the selective increase in sympathetic neuronal activity induced 
by MA would seem to be a metabolically appropriate r sponse 
to blockade of fatty acid oxidation, since previous work has 
demonstrated that neuronal NE, but not adrenal E, serves as 
the physiological mediator of lipolysis in white adipose tissue 
(17,19). These data indicate that mechanisms for energy ho- 
meostasis are finely tuned to detect and compensate for altera- 
tions in availability of specific metabolic fuels. 
Finally, future studies are required to answer specific ques- 
tions related to the subject of MA-induced outflow of neuronal 
NE. The present NE measurements reflect he average spillover 
rate of NE from many organs, which might be affected by neu- 
ronal NE release as well as NE clearance. Microdialysis will be 
performed to identify the vascularity in white adipose tissue as 
the possible source of NE. These studies can also exclude the 
possibility that MA might have some nonspecific effect on sym- 
pathetic activity. 
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